Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BiomX Inc. Director's Dealing 2023

Dec 1, 2023

35099_dirs_2023-12-01_746a44c2-61e8-4a43-9f4d-a0a52a4847db.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BiomX Inc. (PHGE)
CIK: 0001739174
Period of Report: 2023-11-29

Reporting Person: Oron Assaf (Chief Business Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-11-29 Common Stock S 5444 $0.40 Disposed 5470 Direct
2023-11-29 Common Stock S 3414 $0.35 Disposed 2056 Direct
2023-11-29 Common Stock S 2056 $0.34 Disposed 0 Direct